SRL
SNDX icon

Scientech Research LLC’s Syndax Pharmaceuticals SNDX Stock Holding History

Scientech Research LLC’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,875
Closed -$475K – 782
2025
Q3 		$475K Buy
+30,875
New +$404K 0.17% 265
2024
Q2 		– Sell
-23,520
Closed -$560K – 729
2024
Q1 		$560K Buy
+23,520
New +$525K 0.3% 117

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Scientech Research LLC's SNDX Position: Q4 2025 in Review

Scientech Research LLC sold out of Syndax Pharmaceuticals (SNDX) in Q4 2025, closing a stake of 30,875 shares — an estimated $475K sold.

Scientech Research LLC first reported a position in SNDX in Q1 2024 and held it in 2 quarters. The position peaked at $560K in Q1 2024. 229 funds tracked by Wall St. Rank hold SNDX as of Q4 2025.

  • Scientech Research LLC reported no remaining Syndax Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 30,875 Syndax Pharmaceuticals shares in Q4 2025, an estimated $475K.
  • Scientech Research LLC first reported a position in Syndax Pharmaceuticals in Q1 2024 and held it in 2 quarters.
  • Scientech Research LLC's Syndax Pharmaceuticals position peaked at $560K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.